[DOI] [PubMed] [Google Scholar] 116.Spiering B.A., Kraemer W.J., Vingren J.L., Hatfield D.L., Fragala M.S., Ho J.Y., Maresh C.M., Anderson J.M., Volek J.S
Mounjaro (Tirzepatide): Dual GLP-1 & GIP receptor agonist originally approved for type 2 diabetes, now widely used for medical weight loss
Do not make your own medication-holding decision
Seven more large-scale trials (the TRIUMPH program, over 5,800 people total) are still running and will release results throughout 2026
Additionally, if youre in the McKinney area, the Forum Functional Health Center in McKinney, Texas provides specialized care and fatigue treatment options to help you regain your energy and improve your quality of life
As the main antioxidant enzyme in plasma, GPx3 is the only extracellular enzyme in the GPx family that reduces ROS products during normal metabolism or oxidative damage [15]